Inactive Instrument

News HLS Therapeutics Inc Toronto S.E.

Equities

AM

CA05328X1015

Summary

Unlock all the news: Be the first to know and act before the market!

National Bank on DRI Healthcare Trust's Xenpozyme Royalty Stream Acquisition	Jul. 02	MT
HLS Therapeutics Sells Xenpozyme Royalty Interest to DRI Healthcare Trust	Jul. 02	MT
HLS Therapeutics Brief: Announcing Sale of its XENPOZYME Royalty Interest to DRI Healthcare Trust	Jul. 02	MT
HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust	Jul. 02	AQ
HLS Therapeutics Reports Annual Meeting Results	Jun. 07	AQ
Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call	Jun. 07
HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study	May. 28	MT
New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment	May. 28	AQ
HLS Therapeutics Inc. Announces New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment	May. 28	CI
Transcript : HLS Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance	May. 09	MT
Tranche Update on HLS Therapeutics Inc.'s Equity Buyback Plan announced on November 9, 2023.	May. 09	CI
HLS Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
HLS Therapeutics Brief: Q1 2024 revenue was US$12.5 million, Adjusted EBITDA was $2.7 million and cash from operations was $0.8 million	May. 09	MT
HLS Therapeutics Announces Q1 2024 Financial Results	May. 09	AQ
HLS Therapeutics Inc Updates Consolidated Revenue Guidance for the Full Year 2024	May. 09	CI
HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call	Apr. 25	AQ
Tranche Update on HLS Therapeutics Inc.'s Equity Buyback Plan announced on November 9, 2023.	Apr. 12	CI
Tranche Update on HLS Therapeutics Inc.'s Equity Buyback Plan announced on November 10, 2022.	Apr. 12	CI
HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HLS Therapeutics Inc Toronto S.E.

Equities

AM

CA05328X1015

Summary

Filters